OR WAIT null SECS
Feliza Mirasol is the science editor for Pharmaceutical Technology and Pharmaceutical Technology Europe.
February 02, 2021
CDMOs address the unique challenges of liquid and lyophilized forms as well as preparing for the large capacity needed for COVID-19 vaccines.
January 02, 2021
Traditional biologic-based testing methods may need an upgrade to properly test newer therapeutic modalities.
The number of recommendations for European marketing authorization of human medicines saw significant increase in 2020 over the previous year.
December 02, 2020
Early detection and more sensitive methods of detecting adventitious agents are becoming increasingly critical in bioprocessing.
October 03, 2020
The manufacture of gene therapy vectors is shifting to more modern technologies.
August 02, 2020
The early success seen on the market for approved cell and gene therapies poses both technical and manufacturing challenges for pipeline candidates on the road to commercialization.